VALDAGNI, RICCARDO
VALDAGNI, RICCARDO
Dipartimento di Oncologia ed Emato-Oncologia
A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS Study
2022 H.B. Luiting, S. Remmers, E.R. Boevé, R. Valdagni, P.K. Chiu, A. Semjonow, V. Berge, K.H. Tully, A.S. Rannikko, F. Staerman, M.J. Roobol
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer
2022 V. Doldi, M. Lecchi, S. Ljevar, M. Colecchia, E. Campi, G. Centonze, C. Marenghi, T. Rancati, R. Miceli, P. Verderio, R. Valdagni, P. Gandellini, N. Zaffaroni
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
2022 L. Van der Weijst, M.E. Aguado-Barrera, D. Azria, P. Berkovic, P. Boisselier, E. Briers, R. Bultijnck, P. Calvo-Crespo, J. Chang-Claude, A. Choudhury, G. Defraene, S. Demontois, A.M. Dunning, R.M. Elliott, D. Ennis, C. Faivre-Finn, M. Franceschini, S. Gutierrez-Enriquez, C. Herskind, D.S. Higginson, S.L. Kerns, K. Johnson, M. Molla, M. Lambrecht, M. Ramos, T. Rancati, A. Rimner, B.S. Rosenstein, D. De Ruysscher, A. Salem, C. Sangalli, P. Seibold, P. Sosa-Fajardo, E. Sperk, H. Stobart, H. Summersgill, V. Surmont, P. Symonds, B. Taboada-Lorenzo, C.J. Talbot, R. Valdagni, A. Vega, L. Veldeman, M.R. Veldwijk, T. Ward, A. Webb, C.M.L. West, Y. Lievens
Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database
2022 K.R. Beckmann, C.H. Bangma, J. Helleman, A. Bjartell, P.R. Carroll, T. Morgan, D. Nieboer, A. Santaolalla, B.J. Trock, R. Valdagni, M.J. Roobol
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study
2022 L. Nicosia, D. Franceschini, F. Perrone-Congedi, F. Casamassima, M.A. Gerardi, M. Rigo, R. Mazzola, M. Perna, V. Scotti, A. Fodor, A. Iurato, F. Pasqualetti, G. Gadducci, S. Chiesa, R.M. Niespolo, A. Bruni, G. Alicino, L. Frassinelli, P. Borghetti, A. Di Marzo, A. Ravasio, B. De Bari, M. Sepulcri, D. Aiello, G. Mortellaro, C. Sangalli, M. Franceschini, G. Montesi, F.M. Aquilanti, G. Lunardi, R. Valdagni, I. Fazio, G. Scarzello, L. Corti, V. Vavassori, E. Maranzano, S.M. Magrini, S. Arcangeli, M.A. Gambacorta, V. Valentini, F. Paiar, S. Ramella, N.G. Di Muzio, L. Livi, B.A. Jereczek-Fossa, M.F. Osti, M. Scorsetti, F. Alongi
Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
2022 J. Olivier, W. Li, D. Nieboer, J. Helleman, M. Roobol, V. Gnanapragasam, M. Frydenberg, M. Sugimoto, P. Carroll, T.M. Morgan, R. Valdagni, J. Rubio-Briones, G. Robert, P. Stricker, A. Hayen, I. Schoots, M. Haider, C.M. Moore, B. Denton, A. Villers
Almost one year of COVID-19 pandemic : how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study
2021 B.A. Jereczek-Fossa, M.F. Palazzi, S. Tonoli, M. Zaffaroni, G. Marvaso, G.B. Ivaldi, M. Amadori, P. Antognoni, S. Arcangeli, A. Buffoli, G. Beltramo, M. Bignardi, S. Bracelli, A. De Stefani, S. Castiglioni, G. Catalano, N. Di Muzio, A. Cerrotta, L. Fariselli, A.R. Filippi, A. Gramaglia, C. Italia, P. Massaro, S.M. Magrini, S. Nava, E. Orlandi, N. Pasinetti, E.L. Sbicego, L. Scandolaro, M. Scorsetti, C. Barbonetti, R. Tortini, R. Valdagni, V. Vavassori, M. Pepa, L.F. Cazzaniga, C.P. Soatti
Breast cancer patient perspective on opportunities and challenges of a genetic test aimed to predict radio-induced side effects before treatment : Analysis of the Italian branch of the REQUITE project
2021 L. Bellardita, R.R. Colciago, S. Frasca, M.C. De Santis, S. Gay, F. Palorini, E. La Rocca, R. Valdagni, T. Rancati, L. Lozza
Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database
2021 K. Beckmann, A. Santaolalla, J. Helleman, P. Carroll, B. Ha Chung, L. Shiong Lee, A. Perry, J. Rubio-Briones, M. Sugimoto, B. Trock, R. Valdagni, P. Dasgupta, M. Van Hemelrijck, O. Elhage
Hypofractionated whole-breast radiotherapy in large breast size patients : is it really a resolved issue?
2021 R.R. Colciago, A. Cavallo, M.C. Magri, A. Vitullo, E. La Rocca, C. Giandini, F. Bonfantini, S. Di Cosimo, P. Baili, M. Sant, E. Pignoli, R. Valdagni, L. Lozza, M.C. De Santis
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300)
2021 S. Russo, R. Ricotti, S. Molinelli, F. Patti, A. Barcellini, E. Mastella, A. Pella, C. Paganelli, G. Marvaso, M. Pepa, S. Comi, M. Zaffaroni, B. Avuzzi, T. Giandini, E. Pignoli, R. Valdagni, G. Baroni, F. Cattani, M. Ciocca, B.A. Jereczek-Fossa, E. Orlandi, R. Orecchia, B. Vischioni
Prediction of grade reclassification of prostate cancer patients on active surveillance through the combination of a three-mirna signature and selected clinical variables
2021 P. Gandellini, C.M. Ciniselli, T. Rancati, C. Marenghi, V. Doldi, R. El Bezawy, M. Lecchi, M. Claps, M. Catanzaro, B. Avuzzi, E. Campi, M. Colecchia, F. Badenchini, P. Verderio, R. Valdagni, N. Zaffaroni
What is the effect of MRI with targeted biopsies on the rate of patients discontinuing active surveillance? A reflection of the use of MRI in the PRIAS study
2021 H.B. Luiting, S. Remmers, R. Valdagni, E.R. Boeve, F. Staerman, J. Rueb, D.M. Somford, T. Pickles, A. Rannikko, M.J. Roobol
Risk-Based Selection for Active Surveillance : Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Initiative
2021 S.M. Bruinsma, D. Nieboer, M.J. Roobol, C.H. Bangma, J.F.M. Verbeek, V. Gnanapragasam, M. Van Hemelrijck, M. Frydenberg, L.-. Lee, R. Valdagni, C. Logothetis, E.W. Steyerberg
Radiotherapy after testis-sparing surgery for seminoma in monorchid patients : safety and efficacy
2021 B. Avuzzi, A. Tittarelli, S. Andreani, B. Noris Chiorda, E. Seregni, S. Villa, S. Tana, R. Valdagni, R. Salvioni, D. Biasoni, M. Catanzaro, S. Stagni, N. Nicolai
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
2021 N.R. Franco, M.C. Massi, F. Ieva, A. Manzoni, A.M. Paganoni, P. Zunino, L. Veldeman, P. Ost, V. Fonteyne, C.J. Talbot, T. Rattay, A. Webb, K. Johnson, M. Lambrecht, K. Haustermans, G. De Meerleer, D. de Ruysscher, B. Vanneste, E. Van Limbergen, A. Choudhury, R.M. Elliott, E. Sperk, M.R. Veldwijk, C. Herskind, B. Avuzzi, B. Noris Chiorda, R. Valdagni, D. Azria, M.-. Farcy-Jacquet, M. Brengues, B.S. Rosenstein, R.G. Stock, A. Vega, M.E. Aguado-Barrera, P. Sosa-Fajardo, A.M. Dunning, L. Fachal, S.L. Kerns, D. Payne, J. Chang-Claude, P. Seibold, C.M.L. West, T. Rancati
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer : Bowel dose-volume effect quantification in a multicentric cohort study
2021 A. Bresolin, A. Faiella, E. Garibaldi, F. Munoz, D. Cante, V. Vavassori, J.M. Waskiewicz, G. Girelli, B. Avuzzi, E. Villa, A. Magli, B. Noris Chiorda, M. Gatti, L. Ferella, A. Maggio, V. Landoni, S. Aimonetto, C. Sini, T. Rancati, G. Sanguineti, R. Valdagni, N. Di Muzio, C. Fiorino, C. Cozzarini
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300
2021 G. Marvaso, B. Vischioni, M. Pepa, M. Zaffaroni, S. Volpe, F. Patti, F. Bellerba, S. Gandini, S. Comi, G. Corrao, D. Zerini, M. Augugliaro, C. Fodor, S. Russo, S. Molinelli, M. Ciocca, R. Ricotti, F. Valvo, T. Giandini, B. Avuzzi, R. Valdagni, O. De Cobelli, F. Cattani, E. Orlandi, B.A. Jereczek-Fossa, R. Orecchia
Editorial : Modeling for Prediction of Radiation-Induced Toxicity to Improve Therapeutic Ratio in the Modern Radiation Therapy Era
2021 T. Rancati, C. Fiorino, G. Sanguineti, R. Valdagni, E. Orlandi
Predictors of patient-reported incontinence at adjuvant/salvage radiotherapy after prostatectomy : Impact of time between surgery and radiotherapy
2021 F. Munoz, G. Sanguineti, A. Bresolin, D. Cante, V. Vavassori, J.M. Waskiewicz, G. Girelli, B. Avuzzi, E. Garibaldi, A. Faiella, E. Villa, A. Magli, B.N. Chiorda, M. Gatti, T. Rancati, R. Valdagni, N.G. Di Muzio, C. Fiorino, C. Cozzarini